Sign In
Buy XPH
$56.32
+0.615 (+1.10%)
At Close: Jun 03, 2026
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:31am, Thursday, 14'th Dec 2023
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
Pharma ETFs in Focus Post Q3 Earnings
12:46pm, Wednesday, 08'th Nov 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:32am, Monday, 18'th Sep 2023
Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Care ETFs category of the market.
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:31am, Monday, 21'st Aug 2023
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
Cautious on Big Tech & AI? Try These Value-Focused Sector ETFs
02:27pm, Wednesday, 09'th Aug 2023
Value-focused investing comes to rescue if high-growth sectors fail for some reasons.
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:34am, Tuesday, 18'th Jul 2023
Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Care ETFs category of the market.
XPH: Non-Diversified U.S.-Based Large-Cap Pharma ETF Isn't Very Attractive
10:24am, Sunday, 16'th Jul 2023
XPH's consistent low yield and poor price growth (mostly negative) over both short-run as well as over long-run should be disheartening for investors. Expiration of a large number of patents within 20
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
08:03am, Wednesday, 21'st Jun 2023
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the SPDR S&P Pharmaceuticals ETF (XPH), a passively managed exchange traded fund la
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:40am, Thursday, 18'th May 2023
Launched on 06/19/2006, the SPDR S&P Pharmaceuticals ETF (XPH) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.
Pharma ETFs Gain Post Q1 Earnings
01:01pm, Tuesday, 09'th May 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
07:39am, Friday, 21'st Apr 2023
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
XPH: Revenue Challenges Ahead For U.S. Pharmaceuticals
11:52pm, Tuesday, 04'th Apr 2023
XPH gives you exposure to a broad-based cut of the US Pharmaceuticals sector. Patent expirations are a major headwind affecting many companies in the industry.
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:41am, Wednesday, 15'th Mar 2023
Smart Beta ETF report for XPH
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
07:32am, Friday, 13'th Jan 2023
Smart Beta ETF report for XPH
